Global Soft Capsules Drugs CMO Market Growth (Status and Outlook) 2025-2031

September 2025 | 109 pages | ID: G52FDE9C11A3EN
LP Information

Abstracts

According to this study, the global Soft Capsules Drugs CMO market size will reach US$ 11620 million by 2031.

The company supply Softgel Capsule contract pharmaceutical manufacturing services

The global pharmaceutical market is 1475 billion USD in 2022, growing at a CAGR of 5% during the next six years. The pharmaceutical market includes chemical drugs and biological drugs. For biologics is expected to 381 billion USD in 2022. In comparison, the chemical drug market is estimated to increase from 1005 billion in 2018 to 1094 billion U.S. dollars in 2022. The pharmaceutical market factors such as increasing demand for healthcare, technological advancements, and the rising prevalence of chronic diseases, increase in funding from private & government organizations for development of pharmaceutical manufacturing segments and rise in R&D activities for drugs. However, the industry also faces challenges such as stringent regulations, high costs of research and development, and patent expirations. Companies need to continuously innovate and adapt to these challenges to stay competitive in the market and ensure their products reach patients in need. Additionally, the COVID-19 pandemic has highlighted the importance of vaccine development and supply chain management, further emphasizing the need for pharmaceutical companies to be agile and responsive to emerging public health needs.

LPI (LP Information)' newest research report, the “Soft Capsules Drugs CMO Industry Forecast” looks at past sales and reviews total world Soft Capsules Drugs CMO sales in 2024, providing a comprehensive analysis by region and market sector of projected Soft Capsules Drugs CMO sales for 2025 through 2031. With Soft Capsules Drugs CMO sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Soft Capsules Drugs CMO industry.

This Insight Report provides a comprehensive analysis of the global Soft Capsules Drugs CMO landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Soft Capsules Drugs CMO portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Soft Capsules Drugs CMO market.

This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Soft Capsules Drugs CMO and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Soft Capsules Drugs CMO.

This report presents a comprehensive overview, market shares, and growth opportunities of Soft Capsules Drugs CMO market by product type, application, key players and key regions and countries.

Segmentation by Type:

• Gelatin Type
• Non-animal Type

Segmentation by Application:

• Health Supplements
• Pharmaceutical
• Others

This report also splits the market by region:

• Americas
• United States
• Canada
• Mexico
• Brazil
• APAC
• China
• Japan
• Korea
• Southeast Asia
• India
• Australia
• Europe
• Germany
• France
• UK
• Italy
• Russia
• Middle East & Africa
• Egypt
• South Africa
• Israel
• Turkey
• GCC Countries

The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.

• Catalent
• Aenova
• Nature's Bounty
• Procaps
• Patheon (Thermo Fisher Scientific)
• IVC
• EuroCaps
• Captek
• Strides Pharma Science
• Lonza (Capsugel)
• Soft Gel Technologies
• Sirio Pharma

Contents

1 SCOPE OF THE REPORT

1.1 Market Introduction
1.2 Years Considered
1.3 Research Objectives
1.4 Market Research Methodology
1.5 Research Process and Data Source
1.6 Economic Indicators
1.7 Currency Considered
1.8 Market Estimation Caveats

2 EXECUTIVE SUMMARY

2.1 World Market Overview
  2.1.1 Global Soft Capsules Drugs CMO Market Size (2020-2031)
  2.1.2 Soft Capsules Drugs CMO Market Size CAGR by Region (2020 VS 2024 VS 2031)
  2.1.3 World Current & Future Analysis for Soft Capsules Drugs CMO by Country/Region (2020, 2024 & 2031)
2.2 Soft Capsules Drugs CMO Segment by Type
  2.2.1 Gelatin Type
  2.2.2 Non-animal Type
2.3 Soft Capsules Drugs CMO Market Size by Type
  2.3.1 Soft Capsules Drugs CMO Market Size CAGR by Type (2020 VS 2024 VS 2031)
  2.3.2 Global Soft Capsules Drugs CMO Market Size Market Share by Type (2020-2025)
2.4 Soft Capsules Drugs CMO Segment by Application
  2.4.1 Health Supplements
  2.4.2 Pharmaceutical
  2.4.3 Others
2.5 Soft Capsules Drugs CMO Market Size by Application
  2.5.1 Soft Capsules Drugs CMO Market Size CAGR by Application (2020 VS 2024 VS 2031)
  2.5.2 Global Soft Capsules Drugs CMO Market Size Market Share by Application (2020-2025)

3 SOFT CAPSULES DRUGS CMO MARKET SIZE BY PLAYER

3.1 Soft Capsules Drugs CMO Market Size Market Share by Player
  3.1.1 Global Soft Capsules Drugs CMO Revenue by Player (2020-2025)
  3.1.2 Global Soft Capsules Drugs CMO Revenue Market Share by Player (2020-2025)
3.2 Global Soft Capsules Drugs CMO Key Players Head office and Products Offered
3.3 Market Concentration Rate Analysis
  3.3.1 Competition Landscape Analysis
  3.3.2 Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
3.4 New Products and Potential Entrants
3.5 Mergers & Acquisitions, Expansion

4 SOFT CAPSULES DRUGS CMO BY REGION

4.1 Soft Capsules Drugs CMO Market Size by Region (2020-2025)
4.2 Global Soft Capsules Drugs CMO Annual Revenue by Country/Region (2020-2025)
4.3 Americas Soft Capsules Drugs CMO Market Size Growth (2020-2025)
4.4 APAC Soft Capsules Drugs CMO Market Size Growth (2020-2025)
4.5 Europe Soft Capsules Drugs CMO Market Size Growth (2020-2025)
4.6 Middle East & Africa Soft Capsules Drugs CMO Market Size Growth (2020-2025)

5 AMERICAS

5.1 Americas Soft Capsules Drugs CMO Market Size by Country (2020-2025)
5.2 Americas Soft Capsules Drugs CMO Market Size by Type (2020-2025)
5.3 Americas Soft Capsules Drugs CMO Market Size by Application (2020-2025)
5.4 United States
5.5 Canada
5.6 Mexico
5.7 Brazil

6 APAC

6.1 APAC Soft Capsules Drugs CMO Market Size by Region (2020-2025)
6.2 APAC Soft Capsules Drugs CMO Market Size by Type (2020-2025)
6.3 APAC Soft Capsules Drugs CMO Market Size by Application (2020-2025)
6.4 China
6.5 Japan
6.6 South Korea
6.7 Southeast Asia
6.8 India
6.9 Australia

7 EUROPE

7.1 Europe Soft Capsules Drugs CMO Market Size by Country (2020-2025)
7.2 Europe Soft Capsules Drugs CMO Market Size by Type (2020-2025)
7.3 Europe Soft Capsules Drugs CMO Market Size by Application (2020-2025)
7.4 Germany
7.5 France
7.6 UK
7.7 Italy
7.8 Russia

8 MIDDLE EAST & AFRICA

8.1 Middle East & Africa Soft Capsules Drugs CMO by Region (2020-2025)
8.2 Middle East & Africa Soft Capsules Drugs CMO Market Size by Type (2020-2025)
8.3 Middle East & Africa Soft Capsules Drugs CMO Market Size by Application (2020-2025)
8.4 Egypt
8.5 South Africa
8.6 Israel
8.7 Turkey
8.8 GCC Countries

9 MARKET DRIVERS, CHALLENGES AND TRENDS

9.1 Market Drivers & Growth Opportunities
9.2 Market Challenges & Risks
9.3 Industry Trends

10 GLOBAL SOFT CAPSULES DRUGS CMO MARKET FORECAST

10.1 Global Soft Capsules Drugs CMO Forecast by Region (2026-2031)
  10.1.1 Global Soft Capsules Drugs CMO Forecast by Region (2026-2031)
  10.1.2 Americas Soft Capsules Drugs CMO Forecast
  10.1.3 APAC Soft Capsules Drugs CMO Forecast
  10.1.4 Europe Soft Capsules Drugs CMO Forecast
  10.1.5 Middle East & Africa Soft Capsules Drugs CMO Forecast
10.2 Americas Soft Capsules Drugs CMO Forecast by Country (2026-2031)
  10.2.1 United States Market Soft Capsules Drugs CMO Forecast
  10.2.2 Canada Market Soft Capsules Drugs CMO Forecast
  10.2.3 Mexico Market Soft Capsules Drugs CMO Forecast
  10.2.4 Brazil Market Soft Capsules Drugs CMO Forecast
10.3 APAC Soft Capsules Drugs CMO Forecast by Region (2026-2031)
  10.3.1 China Soft Capsules Drugs CMO Market Forecast
  10.3.2 Japan Market Soft Capsules Drugs CMO Forecast
  10.3.3 Korea Market Soft Capsules Drugs CMO Forecast
  10.3.4 Southeast Asia Market Soft Capsules Drugs CMO Forecast
  10.3.5 India Market Soft Capsules Drugs CMO Forecast
  10.3.6 Australia Market Soft Capsules Drugs CMO Forecast
10.4 Europe Soft Capsules Drugs CMO Forecast by Country (2026-2031)
  10.4.1 Germany Market Soft Capsules Drugs CMO Forecast
  10.4.2 France Market Soft Capsules Drugs CMO Forecast
  10.4.3 UK Market Soft Capsules Drugs CMO Forecast
  10.4.4 Italy Market Soft Capsules Drugs CMO Forecast
  10.4.5 Russia Market Soft Capsules Drugs CMO Forecast
10.5 Middle East & Africa Soft Capsules Drugs CMO Forecast by Region (2026-2031)
  10.5.1 Egypt Market Soft Capsules Drugs CMO Forecast
  10.5.2 South Africa Market Soft Capsules Drugs CMO Forecast
  10.5.3 Israel Market Soft Capsules Drugs CMO Forecast
  10.5.4 Turkey Market Soft Capsules Drugs CMO Forecast
10.6 Global Soft Capsules Drugs CMO Forecast by Type (2026-2031)
10.7 Global Soft Capsules Drugs CMO Forecast by Application (2026-2031)
  10.7.1 GCC Countries Market Soft Capsules Drugs CMO Forecast

11 KEY PLAYERS ANALYSIS

11.1 Catalent
  11.1.1 Catalent Company Information
  11.1.2 Catalent Soft Capsules Drugs CMO Product Offered
  11.1.3 Catalent Soft Capsules Drugs CMO Revenue, Gross Margin and Market Share (2020-2025)
  11.1.4 Catalent Main Business Overview
  11.1.5 Catalent Latest Developments
11.2 Aenova
  11.2.1 Aenova Company Information
  11.2.2 Aenova Soft Capsules Drugs CMO Product Offered
  11.2.3 Aenova Soft Capsules Drugs CMO Revenue, Gross Margin and Market Share (2020-2025)
  11.2.4 Aenova Main Business Overview
  11.2.5 Aenova Latest Developments
11.3 Nature's Bounty
  11.3.1 Nature's Bounty Company Information
  11.3.2 Nature's Bounty Soft Capsules Drugs CMO Product Offered
  11.3.3 Nature's Bounty Soft Capsules Drugs CMO Revenue, Gross Margin and Market Share (2020-2025)
  11.3.4 Nature's Bounty Main Business Overview
  11.3.5 Nature's Bounty Latest Developments
11.4 Procaps
  11.4.1 Procaps Company Information
  11.4.2 Procaps Soft Capsules Drugs CMO Product Offered
  11.4.3 Procaps Soft Capsules Drugs CMO Revenue, Gross Margin and Market Share (2020-2025)
  11.4.4 Procaps Main Business Overview
  11.4.5 Procaps Latest Developments
11.5 Patheon (Thermo Fisher Scientific)
  11.5.1 Patheon (Thermo Fisher Scientific) Company Information
  11.5.2 Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Product Offered
  11.5.3 Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Revenue, Gross Margin and Market Share (2020-2025)
  11.5.4 Patheon (Thermo Fisher Scientific) Main Business Overview
  11.5.5 Patheon (Thermo Fisher Scientific) Latest Developments
11.6 IVC
  11.6.1 IVC Company Information
  11.6.2 IVC Soft Capsules Drugs CMO Product Offered
  11.6.3 IVC Soft Capsules Drugs CMO Revenue, Gross Margin and Market Share (2020-2025)
  11.6.4 IVC Main Business Overview
  11.6.5 IVC Latest Developments
11.7 EuroCaps
  11.7.1 EuroCaps Company Information
  11.7.2 EuroCaps Soft Capsules Drugs CMO Product Offered
  11.7.3 EuroCaps Soft Capsules Drugs CMO Revenue, Gross Margin and Market Share (2020-2025)
  11.7.4 EuroCaps Main Business Overview
  11.7.5 EuroCaps Latest Developments
11.8 Captek
  11.8.1 Captek Company Information
  11.8.2 Captek Soft Capsules Drugs CMO Product Offered
  11.8.3 Captek Soft Capsules Drugs CMO Revenue, Gross Margin and Market Share (2020-2025)
  11.8.4 Captek Main Business Overview
  11.8.5 Captek Latest Developments
11.9 Strides Pharma Science
  11.9.1 Strides Pharma Science Company Information
  11.9.2 Strides Pharma Science Soft Capsules Drugs CMO Product Offered
  11.9.3 Strides Pharma Science Soft Capsules Drugs CMO Revenue, Gross Margin and Market Share (2020-2025)
  11.9.4 Strides Pharma Science Main Business Overview
  11.9.5 Strides Pharma Science Latest Developments
11.10 Lonza (Capsugel)
  11.10.1 Lonza (Capsugel) Company Information
  11.10.2 Lonza (Capsugel) Soft Capsules Drugs CMO Product Offered
  11.10.3 Lonza (Capsugel) Soft Capsules Drugs CMO Revenue, Gross Margin and Market Share (2020-2025)
  11.10.4 Lonza (Capsugel) Main Business Overview
  11.10.5 Lonza (Capsugel) Latest Developments
11.11 Soft Gel Technologies
  11.11.1 Soft Gel Technologies Company Information
  11.11.2 Soft Gel Technologies Soft Capsules Drugs CMO Product Offered
  11.11.3 Soft Gel Technologies Soft Capsules Drugs CMO Revenue, Gross Margin and Market Share (2020-2025)
  11.11.4 Soft Gel Technologies Main Business Overview
  11.11.5 Soft Gel Technologies Latest Developments
11.12 Sirio Pharma
  11.12.1 Sirio Pharma Company Information
  11.12.2 Sirio Pharma Soft Capsules Drugs CMO Product Offered
  11.12.3 Sirio Pharma Soft Capsules Drugs CMO Revenue, Gross Margin and Market Share (2020-2025)
  11.12.4 Sirio Pharma Main Business Overview
  11.12.5 Sirio Pharma Latest Developments

12 RESEARCH FINDINGS AND CONCLUSION

List Of Tables

LIST OF TABLES

Table 1. Soft Capsules Drugs CMO Market Size CAGR by Region (2020 VS 2024 VS 2031) & ($ millions)
Table 2. Soft Capsules Drugs CMO Annual Sales CAGR by Country/Region (2020, 2024 & 2031) & ($ millions)
Table 3. Major Players of Gelatin Type
Table 4. Major Players of Non-animal Type
Table 5. Soft Capsules Drugs CMO Market Size CAGR by Type (2020 VS 2024 VS 2031) & ($ millions)
Table 6. Global Soft Capsules Drugs CMO Market Size by Type (2020-2025) & ($ millions)
Table 7. Global Soft Capsules Drugs CMO Market Size Market Share by Type (2020-2025)
Table 8. Soft Capsules Drugs CMO Market Size CAGR by Application (2020 VS 2024 VS 2031) & ($ millions)
Table 9. Global Soft Capsules Drugs CMO Market Size by Application (2020-2025) & ($ millions)
Table 10. Global Soft Capsules Drugs CMO Market Size Market Share by Application (2020-2025)
Table 11. Global Soft Capsules Drugs CMO Revenue by Player (2020-2025) & ($ millions)
Table 12. Global Soft Capsules Drugs CMO Revenue Market Share by Player (2020-2025)
Table 13. Soft Capsules Drugs CMO Key Players Head office and Products Offered
Table 14. Soft Capsules Drugs CMO Concentration Ratio (CR3, CR5 and CR10) & (2023-2025)
Table 15. New Products and Potential Entrants
Table 16. Mergers & Acquisitions, Expansion
Table 17. Global Soft Capsules Drugs CMO Market Size by Region (2020-2025) & ($ millions)
Table 18. Global Soft Capsules Drugs CMO Market Size Market Share by Region (2020-2025)
Table 19. Global Soft Capsules Drugs CMO Revenue by Country/Region (2020-2025) & ($ millions)
Table 20. Global Soft Capsules Drugs CMO Revenue Market Share by Country/Region (2020-2025)
Table 21. Americas Soft Capsules Drugs CMO Market Size by Country (2020-2025) & ($ millions)
Table 22. Americas Soft Capsules Drugs CMO Market Size Market Share by Country (2020-2025)
Table 23. Americas Soft Capsules Drugs CMO Market Size by Type (2020-2025) & ($ millions)
Table 24. Americas Soft Capsules Drugs CMO Market Size Market Share by Type (2020-2025)
Table 25. Americas Soft Capsules Drugs CMO Market Size by Application (2020-2025) & ($ millions)
Table 26. Americas Soft Capsules Drugs CMO Market Size Market Share by Application (2020-2025)
Table 27. APAC Soft Capsules Drugs CMO Market Size by Region (2020-2025) & ($ millions)
Table 28. APAC Soft Capsules Drugs CMO Market Size Market Share by Region (2020-2025)
Table 29. APAC Soft Capsules Drugs CMO Market Size by Type (2020-2025) & ($ millions)
Table 30. APAC Soft Capsules Drugs CMO Market Size by Application (2020-2025) & ($ millions)
Table 31. Europe Soft Capsules Drugs CMO Market Size by Country (2020-2025) & ($ millions)
Table 32. Europe Soft Capsules Drugs CMO Market Size Market Share by Country (2020-2025)
Table 33. Europe Soft Capsules Drugs CMO Market Size by Type (2020-2025) & ($ millions)
Table 34. Europe Soft Capsules Drugs CMO Market Size by Application (2020-2025) & ($ millions)
Table 35. Middle East & Africa Soft Capsules Drugs CMO Market Size by Region (2020-2025) & ($ millions)
Table 36. Middle East & Africa Soft Capsules Drugs CMO Market Size by Type (2020-2025) & ($ millions)
Table 37. Middle East & Africa Soft Capsules Drugs CMO Market Size by Application (2020-2025) & ($ millions)
Table 38. Key Market Drivers & Growth Opportunities of Soft Capsules Drugs CMO
Table 39. Key Market Challenges & Risks of Soft Capsules Drugs CMO
Table 40. Key Industry Trends of Soft Capsules Drugs CMO
Table 41. Global Soft Capsules Drugs CMO Market Size Forecast by Region (2026-2031) & ($ millions)
Table 42. Global Soft Capsules Drugs CMO Market Size Market Share Forecast by Region (2026-2031)
Table 43. Global Soft Capsules Drugs CMO Market Size Forecast by Type (2026-2031) & ($ millions)
Table 44. Global Soft Capsules Drugs CMO Market Size Forecast by Application (2026-2031) & ($ millions)
Table 45. Catalent Details, Company Type, Soft Capsules Drugs CMO Area Served and Its Competitors
Table 46. Catalent Soft Capsules Drugs CMO Product Offered
Table 47. Catalent Soft Capsules Drugs CMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 48. Catalent Main Business
Table 49. Catalent Latest Developments
Table 50. Aenova Details, Company Type, Soft Capsules Drugs CMO Area Served and Its Competitors
Table 51. Aenova Soft Capsules Drugs CMO Product Offered
Table 52. Aenova Soft Capsules Drugs CMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 53. Aenova Main Business
Table 54. Aenova Latest Developments
Table 55. Nature's Bounty Details, Company Type, Soft Capsules Drugs CMO Area Served and Its Competitors
Table 56. Nature's Bounty Soft Capsules Drugs CMO Product Offered
Table 57. Nature's Bounty Soft Capsules Drugs CMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 58. Nature's Bounty Main Business
Table 59. Nature's Bounty Latest Developments
Table 60. Procaps Details, Company Type, Soft Capsules Drugs CMO Area Served and Its Competitors
Table 61. Procaps Soft Capsules Drugs CMO Product Offered
Table 62. Procaps Soft Capsules Drugs CMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 63. Procaps Main Business
Table 64. Procaps Latest Developments
Table 65. Patheon (Thermo Fisher Scientific) Details, Company Type, Soft Capsules Drugs CMO Area Served and Its Competitors
Table 66. Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Product Offered
Table 67. Patheon (Thermo Fisher Scientific) Soft Capsules Drugs CMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 68. Patheon (Thermo Fisher Scientific) Main Business
Table 69. Patheon (Thermo Fisher Scientific) Latest Developments
Table 70. IVC Details, Company Type, Soft Capsules Drugs CMO Area Served and Its Competitors
Table 71. IVC Soft Capsules Drugs CMO Product Offered
Table 72. IVC Soft Capsules Drugs CMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 73. IVC Main Business
Table 74. IVC Latest Developments
Table 75. EuroCaps Details, Company Type, Soft Capsules Drugs CMO Area Served and Its Competitors
Table 76. EuroCaps Soft Capsules Drugs CMO Product Offered
Table 77. EuroCaps Soft Capsules Drugs CMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 78. EuroCaps Main Business
Table 79. EuroCaps Latest Developments
Table 80. Captek Details, Company Type, Soft Capsules Drugs CMO Area Served and Its Competitors
Table 81. Captek Soft Capsules Drugs CMO Product Offered
Table 82. Captek Soft Capsules Drugs CMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 83. Captek Main Business
Table 84. Captek Latest Developments
Table 85. Strides Pharma Science Details, Company Type, Soft Capsules Drugs CMO Area Served and Its Competitors
Table 86. Strides Pharma Science Soft Capsules Drugs CMO Product Offered
Table 87. Strides Pharma Science Soft Capsules Drugs CMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 88. Strides Pharma Science Main Business
Table 89. Strides Pharma Science Latest Developments
Table 90. Lonza (Capsugel) Details, Company Type, Soft Capsules Drugs CMO Area Served and Its Competitors
Table 91. Lonza (Capsugel) Soft Capsules Drugs CMO Product Offered
Table 92. Lonza (Capsugel) Soft Capsules Drugs CMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 93. Lonza (Capsugel) Main Business
Table 94. Lonza (Capsugel) Latest Developments
Table 95. Soft Gel Technologies Details, Company Type, Soft Capsules Drugs CMO Area Served and Its Competitors
Table 96. Soft Gel Technologies Soft Capsules Drugs CMO Product Offered
Table 97. Soft Gel Technologies Soft Capsules Drugs CMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 98. Soft Gel Technologies Main Business
Table 99. Soft Gel Technologies Latest Developments
Table 100. Sirio Pharma Details, Company Type, Soft Capsules Drugs CMO Area Served and Its Competitors
Table 101. Sirio Pharma Soft Capsules Drugs CMO Product Offered
Table 102. Sirio Pharma Soft Capsules Drugs CMO Revenue ($ million), Gross Margin and Market Share (2020-2025)
Table 103. Sirio Pharma Main Business
Table 104. Sirio Pharma Latest Developments

List Of Figures

LIST OF FIGURES

Figure 1. Soft Capsules Drugs CMO Report Years Considered
Figure 2. Research Objectives
Figure 3. Research Methodology
Figure 4. Research Process and Data Source
Figure 5. Global Soft Capsules Drugs CMO Market Size Growth Rate (2020-2031) ($ millions)
Figure 6. Soft Capsules Drugs CMO Sales by Geographic Region (2020, 2024 & 2031) & ($ millions)
Figure 7. Soft Capsules Drugs CMO Sales Market Share by Country/Region (2024)
Figure 8. Soft Capsules Drugs CMO Sales Market Share by Country/Region (2020, 2024 & 2031)
Figure 9. Global Soft Capsules Drugs CMO Market Size Market Share by Type in 2024
Figure 10. Soft Capsules Drugs CMO in Health Supplements
Figure 11. Global Soft Capsules Drugs CMO Market: Health Supplements (2020-2025) & ($ millions)
Figure 12. Soft Capsules Drugs CMO in Pharmaceutical
Figure 13. Global Soft Capsules Drugs CMO Market: Pharmaceutical (2020-2025) & ($ millions)
Figure 14. Soft Capsules Drugs CMO in Others
Figure 15. Global Soft Capsules Drugs CMO Market: Others (2020-2025) & ($ millions)
Figure 16. Global Soft Capsules Drugs CMO Market Size Market Share by Application in 2024
Figure 17. Global Soft Capsules Drugs CMO Revenue Market Share by Player in 2024
Figure 18. Global Soft Capsules Drugs CMO Market Size Market Share by Region (2020-2025)
Figure 19. Americas Soft Capsules Drugs CMO Market Size 2020-2025 ($ millions)
Figure 20. APAC Soft Capsules Drugs CMO Market Size 2020-2025 ($ millions)
Figure 21. Europe Soft Capsules Drugs CMO Market Size 2020-2025 ($ millions)
Figure 22. Middle East & Africa Soft Capsules Drugs CMO Market Size 2020-2025 ($ millions)
Figure 23. Americas Soft Capsules Drugs CMO Value Market Share by Country in 2024
Figure 24. United States Soft Capsules Drugs CMO Market Size Growth 2020-2025 ($ millions)
Figure 25. Canada Soft Capsules Drugs CMO Market Size Growth 2020-2025 ($ millions)
Figure 26. Mexico Soft Capsules Drugs CMO Market Size Growth 2020-2025 ($ millions)
Figure 27. Brazil Soft Capsules Drugs CMO Market Size Growth 2020-2025 ($ millions)
Figure 28. APAC Soft Capsules Drugs CMO Market Size Market Share by Region in 2024
Figure 29. APAC Soft Capsules Drugs CMO Market Size Market Share by Type (2020-2025)
Figure 30. APAC Soft Capsules Drugs CMO Market Size Market Share by Application (2020-2025)
Figure 31. China Soft Capsules Drugs CMO Market Size Growth 2020-2025 ($ millions)
Figure 32. Japan Soft Capsules Drugs CMO Market Size Growth 2020-2025 ($ millions)
Figure 33. South Korea Soft Capsules Drugs CMO Market Size Growth 2020-2025 ($ millions)
Figure 34. Southeast Asia Soft Capsules Drugs CMO Market Size Growth 2020-2025 ($ millions)
Figure 35. India Soft Capsules Drugs CMO Market Size Growth 2020-2025 ($ millions)
Figure 36. Australia Soft Capsules Drugs CMO Market Size Growth 2020-2025 ($ millions)
Figure 37. Europe Soft Capsules Drugs CMO Market Size Market Share by Country in 2024
Figure 38. Europe Soft Capsules Drugs CMO Market Size Market Share by Type (2020-2025)
Figure 39. Europe Soft Capsules Drugs CMO Market Size Market Share by Application (2020-2025)
Figure 40. Germany Soft Capsules Drugs CMO Market Size Growth 2020-2025 ($ millions)
Figure 41. France Soft Capsules Drugs CMO Market Size Growth 2020-2025 ($ millions)
Figure 42. UK Soft Capsules Drugs CMO Market Size Growth 2020-2025 ($ millions)
Figure 43. Italy Soft Capsules Drugs CMO Market Size Growth 2020-2025 ($ millions)
Figure 44. Russia Soft Capsules Drugs CMO Market Size Growth 2020-2025 ($ millions)
Figure 45. Middle East & Africa Soft Capsules Drugs CMO Market Size Market Share by Region (2020-2025)
Figure 46. Middle East & Africa Soft Capsules Drugs CMO Market Size Market Share by Type (2020-2025)
Figure 47. Middle East & Africa Soft Capsules Drugs CMO Market Size Market Share by Application (2020-2025)
Figure 48. Egypt Soft Capsules Drugs CMO Market Size Growth 2020-2025 ($ millions)
Figure 49. South Africa Soft Capsules Drugs CMO Market Size Growth 2020-2025 ($ millions)
Figure 50. Israel Soft Capsules Drugs CMO Market Size Growth 2020-2025 ($ millions)
Figure 51. Turkey Soft Capsules Drugs CMO Market Size Growth 2020-2025 ($ millions)
Figure 52. GCC Countries Soft Capsules Drugs CMO Market Size Growth 2020-2025 ($ millions)
Figure 53. Americas Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 54. APAC Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 55. Europe Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 56. Middle East & Africa Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 57. United States Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 58. Canada Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 59. Mexico Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 60. Brazil Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 61. China Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 62. Japan Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 63. Korea Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 64. Southeast Asia Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 65. India Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 66. Australia Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 67. Germany Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 68. France Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 69. UK Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 70. Italy Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 71. Russia Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 72. Egypt Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 73. South Africa Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 74. Israel Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 75. Turkey Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)
Figure 76. Global Soft Capsules Drugs CMO Market Size Market Share Forecast by Type (2026-2031)
Figure 77. Global Soft Capsules Drugs CMO Market Size Market Share Forecast by Application (2026-2031)
Figure 78. GCC Countries Soft Capsules Drugs CMO Market Size 2026-2031 ($ millions)